Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Chemistry and Laboratory Medicine|September 25, 2024
Synovial fluid D-lactate - a pathogen-specific biomarker for septic arthritis: a prospective multicenter studySvetlana Karbysheva, Paula Morovic, Petri Bellova, et al.Cancer Science|July 2, 2011
Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)Katja Klausz, Sven Berger, Jeroen J Lammerts van Bueren, et al.Molecular Cancer Therapeutics|June 15, 2016
A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector CellsMatthieu Broussas, Nicolas Boute, Barbara Akla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Tumor-Localized Costimulatory T-Cell Engagement by the 4-1BB/HER2 Bispecific Antibody-Anticalin Fusion PRS-343Marlon J Hinner, Rachida Siham Bel Aiba, Thomas J Jaquin, et al.Cancer Research|July 3, 2008
Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodiesMichael Dechant, Wencke Weisner, Sven Berger, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineageTanja Schneider-Merck, Jeroen J Lammerts van Bueren, Sven Berger, et al.Neoplasia (New York, N.Y.)|April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expressionStefanie Derer, Sven Berger, Martin Schlaeth, et al.Pageof 2